Kavini Rathnayake

Mrs. Kavini Rathnayake

University of Alabama in Huntsville, Huntsville, Alabama, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2020 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
KRKavini Rathnayake
Kavini Rathnayake
UPUnnatiben S Patel
Unnatiben S Patel
CPChi Pham
Chi Pham
AMAnna McAlpin
Anna McAlpin
TBTravis Budisalich
Travis Budisalich
SJSurangi N. Jayawardena
Surangi N. Jayawardena

22 September 2022 in Journal of Nanotheranostics
Verified
Journal Article
Open access
PDF file
UPUnnatiben S Patel
Unnatiben S Patel
KRKavini Rathnayake
Kavini Rathnayake
EHEmily C Hunt
Emily C Hunt
NSNirupama Singh
Nirupama Singh
Facing the deadly pandemic caused by the SARS-CoV-2 virus all over the globe, it is crucial to devote efforts to fighting and preventing this infectious virus. Nanomaterials have gained much attention after the approval of lipid nanoparticle-based COVID-19 vaccines by the United States Food and Drug Administration (USFDA). In light of increasing demands for utilizing nanomaterials in the management of COVID-19, this comprehensive review focuses on the role of nanomaterials in the prevention, diagnostics, therapeutics, and vaccine development of COVID-19. First, we highlight the variety of nanomaterials usage in the prevention of COVID-19. We discuss the advantages of nanomaterials as well as their uses in the production of diagnostic tools and treatment methods. Finally, we review the role of nanomaterials in COVID-19 vaccine development. This review offers direction for creating products based on nanomaterials to combat COVID-19.